Top Page
Century Sage Scientific Holdings Ltd
(1450)
Century Sage Scientific Holdings Ltd (1450) vs. iShares MSCI Hong Kong ETF (EWH)
Century Sage Scientific Holdings Ltd Business Overview & Revenue Model
Century Sage Scientific Holdings Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.25B | 1.25B | 1.07B | 425.61M | 202.79M | 153.31M |
| Gross Profit | 549.39M | 599.30M | 566.91M | 189.80M | 60.33M | 55.85M |
| EBITDA | 90.77M | 119.87M | 184.30M | 19.76M | -22.52M | -44.96M |
| Net Income | 54.00M | 81.71M | 119.46M | -9.21M | -61.62M | -97.53M |
Balance Sheet | ||||||
| Total Assets | 1.01B | 923.92M | 754.59M | 446.91M | 422.68M | 498.64M |
| Cash, Cash Equivalents and Short-Term Investments | 235.59M | 113.32M | 149.54M | 50.93M | 111.06M | 12.78M |
| Total Debt | 51.70M | 252.83M | 168.96M | 151.23M | 182.62M | 182.12M |
| Total Liabilities | 522.86M | 510.21M | 452.88M | 343.92M | 334.29M | 392.86M |
| Stockholders Equity | 493.30M | 418.99M | 297.51M | 93.30M | 65.80M | 80.88M |
Cash Flow | ||||||
| Free Cash Flow | 80.73M | -45.69M | 167.14M | -6.90M | 7.43M | -2.52M |
| Operating Cash Flow | 90.66M | -27.58M | 182.99M | -2.08M | 7.81M | -1.61M |
| Investing Cash Flow | -23.23M | -58.44M | -74.47M | 32.34M | 4.28M | -3.18M |
| Financing Cash Flow | -35.38M | 52.47M | -10.28M | -34.83M | 36.10M | 5.00M |
Century Sage Scientific Holdings Ltd Technical Analysis
Century Sage Scientific Holdings Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | HK$2.90B | 34.38 | 8.51% | ― | 12.46% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | €8.36B | 19.19 | 6.90% | 2.98% | -17.90% | 56.67% | |
60 Neutral | HK$685.69M | 6.41 | 27.53% | ― | 421.56% | 328.43% | |
56 Neutral | HK$1.58B | 27.27 | 11.90% | ― | -1.52% | -67.16% | |
56 Neutral | $6.23B | -67.86 | -8.12% | ― | 3.97% | -211.11% | |
48 Neutral | HK$3.01B | -39.47 | -37.61% | ― | -16.86% | -7.51% |
Century Sage Scientific Holdings Ltd Corporate Events
Be Friends Holding Limited has announced an Extraordinary General Meeting (EGM) to be held on November 7, 2025, in Hangzhou City, China. The meeting will address the ratification and approval of an Equity Purchase Agreement and its associated transactions, which have been detailed in a company circular. This move is significant for the company’s strategic operations and may impact its market positioning and shareholder interests.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Be Friends Holding Limited announced a Gross Merchandise Volume (GMV) of approximately RMB2.55 billion for the third quarter of 2025, marking a 12.07% decrease compared to the same period in 2024. However, the cumulative GMV for the first three quarters of 2025 increased by 7.56% compared to the previous year, indicating growth in the company’s operations despite the quarterly decline.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Century Sage Scientific Holdings Ltd announced the grant of 865,000 awarded shares to selected participants under its Share Award Plan, aimed at recognizing and incentivizing key contributors within the company. This move, which includes shares allocated to senior managers and employees, aligns with the company’s strategic objectives and is contingent upon achieving performance targets, potentially impacting the company’s operational efficiency and stakeholder interests.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Century Sage Scientific Holdings Ltd has announced a supplemental agreement related to a significant acquisition. The company is amending the terms and structure of its acquisition of equity interests in a target company, resulting in the partnership becoming an indirect wholly-owned entity and the target company becoming an indirect wholly-owned subsidiary. This strategic move is expected to enhance the company’s operational capabilities and market positioning.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Be Friends Holding Limited has announced a delay in the dispatch of a circular related to its acquisition of the entire equity interests in a target company. The circular, which includes details on the acquisition terms and recommendations from the Independent Board Committee, was initially expected to be sent to shareholders by September 12, 2025. However, the dispatch has been postponed to on or before September 30, 2025, due to the need for additional time to finalize certain information.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Be Friends Holding Limited, operating in the live-streaming e-commerce industry, reported its interim results for the first half of 2025. The company experienced a 9.8% increase in operating revenue, reaching approximately RMB0.62 billion, attributed to the expansion of its live-streaming channels and multi-platform strategies. However, net profit declined by 37.4% due to increased costs in platform traffic acquisition and investments in the “Friends Cloud” intelligent system. The company is focusing on technology-driven strategies and operational efficiency to navigate industry challenges and foster resilience.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Be Friends Holding Limited has announced a transaction involving the acquisition of the entire equity interests in a target company. The valuation of the target company was conducted using the discounted cash flow (DCF) method, which was deemed more appropriate than asset-based or market approaches due to the target’s growth stage and profitability. This acquisition is expected to enhance Be Friends Holding Limited’s market positioning in the education services sector, as the target company has demonstrated sustained profitability and aligns with the company’s strategic growth plans.
The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
Be Friends Holding Limited has announced supplemental information regarding its 2024 Annual Report. The company, which operates with its subsidiaries, is focused on utilizing its 2,550,000 treasury shares in accordance with the Listing Rules, potentially through sale or transfer, based on market conditions and capital management needs. This update does not alter any other information in the Annual Report.
Be Friends Holding Limited, a company incorporated in the Cayman Islands, has announced a board meeting scheduled for August 27, 2025. The meeting will address the approval and publication of the interim results for the first half of 2025 and consider the payment of an interim dividend, if applicable.
Century Sage Scientific Holdings Ltd has announced a significant acquisition, where its subsidiary will acquire 100% equity interests in a target company for RMB180.0 million. This acquisition will make the target company an indirect wholly-owned subsidiary, integrating its financial results into Century Sage’s consolidated statements. The transaction is classified as both a disclosable and connected transaction under Hong Kong’s Listing Rules, necessitating shareholder approval and an independent board review. The move is expected to enhance the company’s market positioning and operational capabilities.